Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain
1 other identifier
interventional
431
1 country
4
Brief Summary
The goals of the study are to determine the pneumococcal polysaccharide vaccination rate in patients with diabetes before and after community pharmacist education and intervention. Assess barriers of receiving the pneumococcal polysaccharide vaccine in patients with diabetes after pharmacist education in a supermarket chain setting
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2018
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2019
CompletedMarch 15, 2019
March 1, 2019
4 months
February 18, 2019
March 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in vaccination rates
Percentage of patients with diabetes in a national grocery chain pharmacy who received the pneumococcal polysaccharide vaccine before the intervention compared to the percentage who received the vaccination after the intervention.
4 months
Secondary Outcomes (1)
Barriers to receiving vaccination
4 months
Study Arms (1)
Pharmacist Vaccine Education
EXPERIMENTALInterventions
When an eligible patient presents to the pharmacy for prescription pick up or drop off, the pop-up note will notify the technician to get a pharmacist for education. The pharmacist will educate the patient on the vaccine and then recommend that the patient receives the vaccine.
Eligibility Criteria
You may qualify if:
- Patients with diabetes
- Patients who have filled a prescription for at least one diabetes medication in the past 90 days
You may not qualify if:
- Patients with a known history pneumococcal polysaccharide vaccination
- Patients with an allergy to any component of the pneumococcal polysaccharide vaccine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Kroger Pharmacy
Midlothian, Virginia, 23113, United States
Kroger Pharmacy
Richmond, Virginia, 23230, United States
Kroger Pharmacy
Richmond, Virginia, 23233, United States
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
Related Publications (1)
Page A, Harrison A, Nadpara P, Goode JR. Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy. J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S51-S55.e1. doi: 10.1016/j.japh.2020.02.007. Epub 2020 Mar 17.
PMID: 32192948DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Venable Goode, Pharm.D., BCPS, FAPhA, FCCP
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 18, 2019
First Posted
February 22, 2019
Study Start
November 1, 2018
Primary Completion
February 28, 2019
Study Completion
February 28, 2019
Last Updated
March 15, 2019
Record last verified: 2019-03